Education Courses
pda.org/courses
DATES
Denotes
COURSE NAME
1/26 1/30
2/23 2/27
3/9 3/13
3/19 3/20
3/19
3/19
3/19
Applying Six Sigma Techniques to the Process Validation Lifecycle New Course
3/19 3/20
3/20
3/23 3/27
4/13 4/17
4/20 4/23
4/20
4/21 4/22
4/23
4/27 4/29
5/4 5/7
5/6 5/7
Validation of Lyophilization
5/13
SOLD OUT
SOLD OUT
5/4 5/5
5/11 5/12
LOCATION
5/18 5/22
6/15 6/19
5/20 5/21
5/20
5/21
Implementing Quality Risk Management for Pharmaceutical and Biotechnology Manufacturing Operations:
Case Studies in the Packaging and Labeling of Drug Products
5/22
6/1 6/3
SOLD OUT
TYPE
Bethesda, MD
Lab
Bethesda, MD
Lab
Las Vegas, NV
Lecture
Bethesda, MD
Lab
Bethesda, MD
Lecture
Bethesda, MD
Lab
Bethesda, MD
Lecture
Bethesda, MD
Lab
Bethesda, MD
Lecture
Bethesda, MD
Lab
Baltimore, MD
Lecture
Baltimore, MD
Lecture
Bethesda, MD
Lab
6/4
Bethesda, MD
Lecture
6/9 6/10
Bethesda, MD
Lab
6/11 6/12
San Diego, CA
Lecture
6/11
6/11
Validation of Moist Heat Sterilization Processes: Cycle Design, Development, Validation and Ongoing Control
6/12
6/12
Parametric Release of Pharmaceutical and Medical Device Products Sterilized with Moist Heat
6/25 6/26
Bethesda, MD
Lab
Lecture
7/7
Bethesda, MD
Lecture
7/8
Bethesda, MD
Lecture
Instructors:
Carol Lampe, Trainer and Consultant
Brent Watkins, Southeast Sales Manager, Veltek Associates Inc.
pda.org/fap1
pda.org/courses
NEW COURSE
This course will provide an opportunity to discuss the components of a quality culture, how to measure those
components and strategies for enacting change. Through a combination of lecture and small group exercises, this course will enable
you to evaluate your company culture and come up with ideas on how to improve it.
Prerequisites
Participants should read ICH Q10 and the article, The Quality Culture and its Measurement, by R. Kieffer. Class attendees are asked to
bring their thoughts and perspectives on their own companys culture.
Instructor:
Robert G. Kieffer, PhD, President, RGK Consulting
NEW COURSE
Applying Six Sigma Techniques to the Process Validation Lifecycle (March 19)
Review the fundamental steps in the Six Sigma process, discuss the use of risk assessments in assigning appropriate
sample sizes, and provide case studies in the appropriate data analysis across the lifecycle. The primary focus in this one-day course
will be on stage 2b Process Performance Qualification (PPQ).
Instructor:
Mike Long, Director, Consulting Services, ValSource, LLC
pda.org/courses
pdaannualmeeting.org/courses
pda.org/courses
pda.org/2015aseptic
pda.org/courses
Identification of SMEs
Organizational Readiness
What Belongs in a Department Trainers Curriculum
First-Time Observation of Trainers
Department Trainers Employee Qualification
Prerequisites
Participants are encouraged to review their current training processes/SOPs as they will be asked to reference them during the course.
Instructor:
Vivian Bringslimark, President, HPIS Consulting, Inc.
Learning, Knowledge Management and Impact: Moving from Theory to Practice (April 21 22)
In this course, key theories that describe knowledge management and how people learn will be examined. You will find ways to
apply these theories to some of the practical challenges faced in the pharmaceutical/biopharmaceutical industry, such as knowledge
acquisition and transfer, procedure writing and training, new employee on-boarding, web-based learning, and assessment and
evaluation. A large portion of this course will involve identifying best practices, both inside the industry and beyond, and using this
information, along with the groups experience and creativity, to reimagine what can be done differently.
Prerequisites
Participants should have familiarity with current training approaches (e.g., instructional design) and regulatory expectations. Prior to
the session, participants will be provided with a reading list of recommended resources.
Instructor:
James Vesper,President,LearningPlus, Inc
pda.org/trainer
pda.org/courses
pda.org/biotechclean
pda.org/courses
Source: Texwipe
Lyophilization Week
May 4 7, 2015
pda.org/lyo
pda.org/courses
pda.org/MAP
NEW COURSE
pda.org/prevention
10
pda.org/courses
pda.org/courses
11
pda.org/packagingcourses
12
pda.org/courses
pda.org/techdevelop
pda.org/apmanagement
pda.org/courses
13
pda.org/simulation
pda.org/cleaning
14
pda.org/courses
Instructor:
Marsha Stabler Hardiman, Senior Consultant, Concordia
ValSource, LLC
Instructor:
Olivia Henderson, PhD, Principal Scientist, Protein
Pharmaceutical Development, Biogen Idec
pda.org/sterilizationcourses
pda.org/courses
15
pda.org/suscourses
16
pda.org/courses
pda.org/bulkdrug
pdas.org/capa
pda.org/courses
17
pda.org/moistheat
18
pda.org/courses
pda.org/risk
pda.org/air
pda.org/courses
19
pda.org/depyro
GMP Week
pda.org/gmp
20
pda.org/courses
pda.org/enviro
NEW COURSE
pda.org/EMP
pda.org/courses
21
Identification and Classification of Nonconformities in Molded and Tubular Glass Containers for
Pharmaceutical Manufacturing (September 14)
Through a series of lecture presentations accompanied by visual depictions of glass nonconformities, students will be provided with a
review of current best practices for identification and classification of visual nonconformities in glass containers. The course will also present
criteria such as the development and use of appropriate sampling plans for incoming inspection of glass containers and the appropriate
application of Acceptable Quality Limits for accept/reject decisions. The importance of the partnership between glass manufacturers and
the pharmaceutical company using the glass containers in establishing glass container quality specifications will be emphasized.
Instructor:
Nicholas R. Debello, Principal,DeBello & Associates LLC
Instructors will discuss what foreign particulates are and why it is important to identify their composition and potential sources. Three
analytical techniques will be covered polarized light microscopy, infrared spectroscopy and scanning electron microscopy. Students will
get hands-on training in sample preparation, sample analysis and sample interpretation. After the course, students will have developed
particle isolation and particle handing skills and be able to explain the analytical methods used in identifying particulate matter.
Instructors:
Rich Brown,Executive Director, MVA Scientific Consultants
Mary Miller,Executive Director, MVA Scientific Consultants
Ming Zhou,Business Development, MVA Scientific Consultants
pda.org/glassqual
22
pda.org/courses
pda.org/statistics
pda.org/courses
23
Risk-Based Product Development Basics for Combination Products: Harmonizing Design Controls and
Quality-by-Design in Product Development and Market Authorization Documents (October 1)
This course provides an overview of the challenges encountered in developing a combination product. It focuses on drug-device or
biologic-device products with an emphasis on how the controlled development process (design control and QbD) and the associated
documentation of product and process development can support good regulatory submissions. The objective of the course is to
introduce and harmonize the basic requirements of FDAs design controls (21 CFR 820.30) with Quality-by-Design expectations.
Instructor:
Carol DeSain, President, The Tamarack Group North Shore, LLC
24
pda.org/courses
pda.org/pdacourses
pda.org/courses
25
Filtration Week
Filters and Filtration in the Biopharmaceutical Industry: Basics Course (October 12 13)
This highly interactive training course is intended to provide a fundamental understanding of biopharmaceutical filtrations and filters
that will enable the participants to concentrate on the use of filters for the demanding and critical operations for the manufacture of
aseptic products. Practical applications and experiences of filter usage, economics and performance of system designs, integrity test
methods, and process validation of filter devices will be the focus.
Instructors:
Maik Jornitz, CEO, G-Con
Wayne Garafola, Field Application Specialist Biotechnology Division, Sartorius Stedim Biotech
Filters and Filtration in the Biopharmaceutical Industry: Advanced Course (October 14 16)
This advanced course is a three-day laboratory course comprising 30% lecture and 70% hands-on training. The combination of
theoretical and practical work makes this course a highly valuable learning experience for end-users, trainers and regulators.
Coursework includes measurement of unspecific adsorption on different filter membrane polymers and the implication of such
adsorption for any filtration process. Since filter sizing and optimal filter combination choice is essential for biopharmaceutical
filtration processes, the course also includes filterability trials, sizing and scaling. Interactivegroup work will include determining
optimal filter combination for particular case studies detailed by the faculty.
Instructors:
Maik Jornitz, CEO, G-Con
Wayne Garafola, Field Application Specialist Biotechnology Division, Sartorius Stedim Biotech
pda.org/filtration
26
pda.org/courses
pda.org/sterilization
pda.org/microcourses
pda.org/courses
27
Identify applicable international regulatory and compendial requirements for visual inspection
Apply the critical parameters which must be controlled for reproducible inspection results
Use appropriate statistical tools to assess and compare inspection methods
Develop consistent validation strategies for visual inspection processes and equipment
Instructors:
John Shabushnig, PhD, Independent Consultant, Insight Pharma Consulting, Inc.
Ronald Leversee,QA External Operations, Perrigo Company
Matt Ostrowski,Injectable Inspection Team Leader, Pfizer, Inc.
pda.org/visualcourse
28
pda.org/courses
Implementation of Quality Risk Management: Case Studies in the Manufacturing of Biotechnological Bulk
Drug Substances (November 11 12)
This course will consist of lectures and workshops designed to help participants identify risks in bioprocesses.Participants will work in
small groups on open-ended scenarios to identify risk groups and judge their magnitudes and potential impacts. The workshops will
include training in particular risk tools that are introduced throughout the course. Participants will gain increased awareness of risks
and strategies for risk reduction in bioprocess development and manufacturing.
Instructor:
Scott Rudge, PhD, COO, RMC Pharmaceutical Solutions, Inc.
pda.org/riskmanage
pda.org/courses
29
pda.org/metricscourse
pda.org/vaccinescourses
30
pda.org/courses
Developed it
Invented It
Tested It
Know It
Aseptic Processing
Biotechnology
Environmental Monitoring
Filtration
Validation
Quality Control
Regulatory Affairs
pda.org/qualityAP
Instructors:
Carol Lampe, Trainer and Consultant
Brent Watkins, Southeast Sales Manager, Veltek Associates Inc.
pda.org/FAP2
32
pda.org/courses
DATES
COURSE NAME
LOCATION
7/21 7/23
7/21
7/22
Validation of Moist Heat Sterilization Processes: Cycle Design, Development, Validation and Ongoing Control
7/23
Steam in Place
TYPE
Bethesda, MD
Lecture
7/27 7/29
Bethesda, MD
Lab
8/3 8/7
8/24 8/28
Bethesda, MD
Lab
SOLD OUT
8/10 8/11
Bethesda, MD
Lab
8/12 8/14
Validation of Dry Heat Processes Used for Sterilization and Depyrogenation | pda.org/depyro Bethesda, MD
Lab
8/17 8/19
8/17
8/18 8/19
Bethesda, MD
Lecture
Bethesda, MD
Lab
Bethesda, MD
Lecture
9/14 9/18
Glass Quality, Visual Inspection and Foreign Material Identification Week | pda.org/glassqual
Bethesda, MD
Lecture/Lab
9/14
Bethesda, MD
Lecture
10/1 10/2
Washington, DC
Lecture
10/1
Risk-Based Product Development Basics for Combination Products: Harmonizing Design Controls and Qualityby-Design in Product Development and Market Authorization Documents
10/1 10/2
10/1 10/2
10/1 10/2
10/2
Bethesda, MD
Lab
Bethesda, MD
Lecture/Lab
Bethesda, MD
Lab
Bethesda, MD
Lecture
Bethesda, MD
Lab
Bethesda, MD
Lecture
Bethesda, MD
Lecture
Bethesda, MD
Lab
Bethesda, MD
Lecture
Bethesda, MD
Lab
9/9 9/10
9/11
9/15 9/16
9/17 9/18
9/22
10/5 10/9
11/2 11/6
10/12 10/16
10/12 10/13
10/14 10/16
10/21 10/23
10/22 10/23
10/22
10/22 10/23
Evaluation, Validation and Implementation of Alternative and Rapid Microbiological Testing Methods
10/23
10/28 10/29
11/9 11/12
11/9 11/10
11/11
Implementation of Quality Risk Management: Case Studies in the Manufacturing of Pharmaceutical Drug Products
11/11 11/12
Implementation of Quality Risk Management: Case Studies in the Manufacturing of Biotechnological Bulk
Drug Substances
11/11
11/16 11/20
12/3 12/4
12/3
12/4
12/7 12/11
REGISTRATION INFORMATION: You can register for PDA courses one of three ways: online, fax or mail. To register online, please visit pda.org/courses,
find your course of choice and click the Register Now button. You may also submit a registration form along with payment information by fax or postal
mail. Please visit pda.org/triregistration for more information. If you have any questions, please call 301-656-5900 ext. 115.
Current as of 5/1/15
PDAs U.S. Education Courses cover a broad range of subject areas reflecting PDAs core competencies
aseptic processing, biotechnology, environmental monitoring, filtration, microbiology, quality/regulatory affairs,
and validation, as well as specialized areas such as lyophilization, pre-filled syringes and visual inspection.
Consistent with PDAs strategic plan, the courses are updated regularly and new offerings are added to reflect
current and upcoming technical, scientific and regulatory topics within those core competencies.
pda.org/courses